{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:35:11Z","timestamp":1793342111068,"version":"4.5.0"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472654"],"award-info":[{"award-number":["82472654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170758"],"award-info":[{"award-number":["82170758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373085"],"award-info":[{"award-number":["82373085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974364"],"award-info":[{"award-number":["81974364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172674"],"award-info":[{"award-number":["82172674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2023KJ095"],"award-info":[{"award-number":["2023KJ095"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["B2214"],"award-info":[{"award-number":["B2214"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Key Medical Discipline","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As the third most common cause of cancer-related mortality, hepatocellular carcinoma (HCC) is a global health concern. Despite its prevalence, treatment options are limited, underscoring the need to identify potential therapeutic targets and strategies. In this study, we identified amplification of cAMP response element-binding protein\u2013regulated transcription coactivator 2 (CRTC2), situated in the 1q21.3 region, due to copy-number alterations in HCC. In a cohort of patients with HCC, CRTC2 protein levels were frequently elevated and correlated with poor prognosis. Genetic deletion of Crtc2 significantly impeded the onset and progression of HCC in mouse models. CRTC2 formed cytoplasmic condensates that recruited the N6-methyladenosine (m6A) reader YTHDF2. Furthermore, CRTC2 promoted the translocation of m6A-modified mRNAs from decay sites to polyribosomes by interacting with PABP1. The activities of CRTC2 counteracted YTHDF2-mediated mRNA degradation to enhance the translational efficiency of specific mRNAs, including those encoding LRP5 and c-Jun. Targeting Crtc2 in hepatocytes using AAV8.sgCrtc2 elicited substantial therapeutic benefits in HCC mouse models and significantly enhanced the sensitivity to lenvatinib. Together, this research elucidates the pivotal role and underlying molecular mechanisms of CRTC2 in hepatocarcinogenesis and lenvatinib resistance, highlighting its potential clinical and therapeutic applications.<\/jats:p>\n                  <jats:p>Significance: CRTC2 hijacks the YTHDF2\u2013m6A pathway to increase translation of c-Jun and promote hepatocellular carcinoma development and lenvatinib resistance, indicating that CRTC2 is a promising biomarker and therapeutic target.<\/jats:p>","DOI":"10.1158\/0008-5472.can-24-3196","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:42:16Z","timestamp":1741092136000},"page":"2046-2066","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-5261","authenticated-orcid":false,"given":"Meixi","family":"Wang","sequence":"first","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7386-3638","authenticated-orcid":false,"given":"Fangdi","family":"Zou","sequence":"additional","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4149-9333","authenticated-orcid":false,"given":"Shengxin","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-7178","authenticated-orcid":false,"given":"Yichen","family":"Yang","sequence":"additional","affiliation":[{"name":"2Tianjin Cancer Institute, Tianjin Key Laboratory of Digestive Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6553-425X","authenticated-orcid":false,"given":"Cong","family":"Xia","sequence":"additional","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-7671","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"3Department of Hepatobiliary Cancer, Liver Cancer Research Center, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-5397","authenticated-orcid":false,"given":"Ben","family":"Liu","sequence":"additional","affiliation":[{"name":"4Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6963-558X","authenticated-orcid":false,"given":"Lian","family":"Li","sequence":"additional","affiliation":[{"name":"4Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-3679","authenticated-orcid":false,"given":"Mulin Jun","family":"Li","sequence":"additional","affiliation":[{"name":"5Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4993-6554","authenticated-orcid":false,"given":"Haixin","family":"Li","sequence":"additional","affiliation":[{"name":"6Cancer Biobank, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1041-4405","authenticated-orcid":false,"given":"Weijie","family":"Song","sequence":"additional","affiliation":[{"name":"7Laboratory Animal Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-8838","authenticated-orcid":false,"given":"Ruifang","family":"Niu","sequence":"additional","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-6895","authenticated-orcid":false,"given":"Zhiyong","family":"Yuan","sequence":"additional","affiliation":[{"name":"8Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5301-7610","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"9State Key Laboratory of Experimental Hematology, Key Laboratory of Cellular and Molecular Immunology in Tianjin, and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-2152","authenticated-orcid":false,"given":"Xiangchun","family":"Li","sequence":"additional","affiliation":[{"name":"2Tianjin Cancer Institute, Tianjin Key Laboratory of Digestive Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-7681","authenticated-orcid":false,"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[{"name":"4Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-9527","authenticated-orcid":false,"given":"Zhiqiang","family":"Wu","sequence":"additional","affiliation":[{"name":"8Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-801X","authenticated-orcid":false,"given":"Zeyun","family":"Mi","sequence":"additional","affiliation":[{"name":"1Department of Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2025060203075643100_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025060203075643100_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"2025060203075643100_bib3","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025060203075643100_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2025060203075643100_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2019.09.010","article-title":"Molecular therapies for HCC: looking outside the box","volume":"72","author":"Faivre","year":"2020","journal-title":"J Hepatol"},{"key":"2025060203075643100_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"2025060203075643100_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"2025060203075643100_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat Cancer"},{"key":"2025060203075643100_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","article-title":"Signatures of copy number alterations in human cancer","volume":"606","author":"Steele","year":"2022","journal-title":"Nature"},{"key":"2025060203075643100_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng.3641","article-title":"Punctuated copy number evolution and clonal stasis in triple-negative breast cancer","volume":"48","author":"Gao","year":"2016","journal-title":"Nat Genet"},{"key":"2025060203075643100_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","article-title":"Genomic basis for RNA alterations in cancer","volume":"578","author":"PCAWG Transcriptome Core Group","year":"2020","journal-title":"Nature"},{"key":"2025060203075643100_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s43018-023-00711-y","article-title":"Aneuploidy and complex genomic rearrangements in cancer evolution","volume":"5","author":"Baker","year":"2024","journal-title":"Nat Cancer"},{"key":"2025060203075643100_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"2025060203075643100_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.gastro.2021.08.052","article-title":"Single-cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma","volume":"162","author":"Guo","year":"2022","journal-title":"Gastroenterology"},{"key":"2025060203075643100_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025060203075643100_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4093\/dmj.2019.0200","article-title":"Role of CRTC2 in metabolic homeostasis: key regulator of whole-body energy metabolism?","volume":"44","author":"Han","year":"2020","journal-title":"Diabetes Metab J"},{"key":"2025060203075643100_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12079-023-00730-5","article-title":"Biological functions of CRTC2 and its role in metabolism-related diseases","volume":"17","author":"Zheng","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"2025060203075643100_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2009.01.007","article-title":"TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1","volume":"9","author":"Ryu","year":"2009","journal-title":"Cell Metab"},{"key":"2025060203075643100_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s42003-021-02735-5","article-title":"Activation of the adipocyte CREB\/CRTC pathway in obesity","volume":"4","author":"Yoon","year":"2021","journal-title":"Commun Biol"},{"key":"2025060203075643100_bib20","doi-asserted-by":"crossref","first-page":"101402","DOI":"10.1016\/j.molmet.2021.101402","article-title":"A novel role of CRTC2 in promoting nonalcoholic fatty liver disease","volume":"55","author":"Han","year":"2022","journal-title":"Mol Metab"},{"key":"2025060203075643100_bib21","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.32439","article-title":"Diabetes medications and risk of HCC","volume":"76","author":"Plaz Torres","year":"2022","journal-title":"Hepatology"},{"key":"2025060203075643100_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025060203075643100_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2021.07.025","article-title":"Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention","volume":"75","author":"Lange","year":"2021","journal-title":"J Hepatol"},{"key":"2025060203075643100_bib24","doi-asserted-by":"crossref","first-page":"eaaw6455","DOI":"10.1126\/sciadv.aaw6455","article-title":"The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer","volume":"5","author":"Rod\u00f3n","year":"2019","journal-title":"Sci Adv"},{"key":"2025060203075643100_bib25","doi-asserted-by":"crossref","first-page":"1533033820962111","DOI":"10.1177\/1533033820962111","article-title":"Phosphorylation of CREB-specific coactivator CRTC2 at Ser238 promotes proliferation, migration, and invasion of colorectal cancer cells","volume":"19","author":"Wang","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"2025060203075643100_bib26","doi-asserted-by":"crossref","first-page":"100799","DOI":"10.1016\/j.neo.2022.100799","article-title":"Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer","volume":"29","author":"Carper","year":"2022","journal-title":"Neoplasia"},{"key":"2025060203075643100_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025060203075643100_bib28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025060203075643100_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in Cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"2025060203075643100_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol Cancer"},{"key":"2025060203075643100_bib31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"2025060203075643100_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-024-01546-5","article-title":"Small molecule inhibitors targeting m6A regulators","volume":"17","author":"Feng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"2025060203075643100_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41419-021-03763-z","article-title":"RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1\/Wnt\/\u03b2-catenin signaling","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"2025060203075643100_bib34","doi-asserted-by":"crossref","first-page":"e2104578","DOI":"10.1002\/advs.202104578","article-title":"cAMP-induced nuclear condensation of CRTC2 promotes transcription elongation and cystogenesis in autosomal dominant polycystic kidney disease","volume":"9","author":"Mi","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"2025060203075643100_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.22747","article-title":"Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through \u03b2-catenin-EGFR-PI3K-Akt-mTOR signaling pathway","volume":"57","author":"Zhang","year":"2018","journal-title":"Mol Carcinog"},{"key":"2025060203075643100_bib36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/gutjnl-2012-304037","article-title":"A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma","volume":"63","author":"Chan","year":"2014","journal-title":"Gut"},{"key":"2025060203075643100_bib37","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1038\/ncomms9651","article-title":"Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53","volume":"6","author":"Fei","year":"2015","journal-title":"Nat Commun"},{"key":"2025060203075643100_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhep.2022.10.037","article-title":"Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses","volume":"78","author":"Yuen","year":"2023","journal-title":"J Hepatol"},{"key":"2025060203075643100_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/JHC.S450460","article-title":"Advances in the pathogenesis of metabolic liver disease-related hepatocellular carcinoma","volume":"11","author":"Chen","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"2025060203075643100_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"2025060203075643100_bib41","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/ijc.28610","article-title":"Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice","volume":"134","author":"Chappell","year":"2014","journal-title":"Int J Cancer"},{"key":"2025060203075643100_bib42","first-page":"2931","article-title":"SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells","volume":"11","author":"Tai","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"2025060203075643100_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nbt.4201","article-title":"Efficient proximity labeling in living cells and organisms with TurboID","volume":"36","author":"Branon","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025060203075643100_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","article-title":"m6A enhances the phase separation potential of mRNA","volume":"571","author":"Ries","year":"2019","journal-title":"Nature"},{"key":"2025060203075643100_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13238-019-00660-2","article-title":"Binding to m6A RNA promotes YTHDF2-mediated phase separation","volume":"11","author":"Wang","year":"2020","journal-title":"Protein Cell"},{"key":"2025060203075643100_bib46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"2025060203075643100_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2025060203075643100_bib48","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2025060203075643100_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40164-020-00197-9","article-title":"AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL","volume":"10","author":"Wu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"2025060203075643100_bib50","doi-asserted-by":"crossref","first-page":"e45947","DOI":"10.15252\/embr.201845947","article-title":"Translation acrobatics: how cancer cells exploit alternate modes of translational initiation","volume":"19","author":"Sriram","year":"2018","journal-title":"EMBO Rep"},{"key":"2025060203075643100_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature18954","article-title":"eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation","volume":"536","author":"Lee","year":"2016","journal-title":"Nature"},{"key":"2025060203075643100_bib52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1134\/S0006297913130014","article-title":"Poly(A)-binding proteins: structure, domain organization, and activity regulation","volume":"78","author":"Eliseeva","year":"2013","journal-title":"Biochemistry (Mosc)"},{"key":"2025060203075643100_bib53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"2025060203075643100_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"2025060203075643100_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m6A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2025060203075643100_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","article-title":"Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer","volume":"37","author":"Yang","year":"2022","journal-title":"J Adv Res"},{"key":"2025060203075643100_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","article-title":"O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025060203075643100_bib58","doi-asserted-by":"crossref","first-page":"e2302025","DOI":"10.1002\/advs.202302025","article-title":"HSP90\u03b2 impedes STUB1-induced ubiquitination of YTHDF2 to drive sorafenib resistance in hepatocellular carcinoma","volume":"10","author":"Liao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2025060203075643100_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","article-title":"YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma","volume":"18","author":"Hou","year":"2019","journal-title":"Mol Cancer"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-3196\/3549885\/can-24-3196.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2046\/3608623\/can-24-3196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2046\/3608623\/can-24-3196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:08:15Z","timestamp":1748833695000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/11\/2046\/762572\/CRTC2-Forms-Co-Condensates-with-YTHDF2-That"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,3,4]]},"published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-3196","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7851702","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.29209380","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209350","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209371","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209377","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209347","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209368","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}